Malcolm A. S. Moore (born January 18, 1944) is a British American biologist who is the Enid A. Haupt Chair of Cell Biology at the

Memorial Sloan-Kettering Cancer Center Memorial Sloan Kettering Cancer Center (MSK or MSKCC) is a oncology, cancer treatment and research institution in Manhattan in New York City. MSKCC is one of 72 National Cancer Institute–NCI-designated Cancer Center, designated Comprehen ...

. Moore is an

oncologist Oncology is a branch of medicine that deals with the study, treatment, diagnosis, and prevention of cancer. A medical professional who practices oncology is an ''oncologist''. The name's etymological origin is the Greek word ὄγκος (''� ...

and

hematologist Hematology ( spelled haematology in British English) is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. It involves treating diseases that affect the production ...

known for being the principal investigator in the development of

filgrastim Filgrastim, sold under the brand name Neupogen among others, is a medication used to treat low neutrophil count. Low neutrophil counts may occur with HIV/AIDS, following chemotherapy or radiation poisoning, or be of an unknown cause. It may ...

. He is a member of various national and international societies and is on the editorial boards of a number of journals. He has served or chaired committees of governmental and professional organizations.

References

External links

Moore’s page at Memorial Sloan-Kettering Cancer Center

G-CSF: its relationship to leukemia differentiation-inducing activity and other hemopoietic regulators
{{DEFAULTSORT:Moore, Malcolm A. S. British oncologists 1944 births Living people